| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 06/19/2013 | CN101146824B Means and methods for breaking noncovalent binding interactions between molecules |
| 06/18/2013 | US8466264 Crystal structures of neuropilin fragments and neuropilin-antibody complexes |
| 06/18/2013 | US8465750 Staphylococcus aureus proteins and nucleic acids |
| 06/18/2013 | CA2481512C Peptide inhibitors of protein kinase c.gamma. for pain management |
| 06/18/2013 | CA2446087C Recombinant tumor specific antibody and use thereof |
| 06/18/2013 | CA2440028C Rearranged squamous cell carcinoma antigen genes ii |
| 06/18/2013 | CA2439042C Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 06/13/2013 | WO2013086216A1 Improved aspartyl-trna synthetases |
| 06/13/2013 | WO2013085368A1 Fusion polypeptide comprising protein scaffold and method for screening the peptide library specific for target protein using the same |
| 06/13/2013 | WO2013083095A1 Novel antibiotic preparation method and platform system based on same |
| 06/13/2013 | US20130150566 Tumor-targeted tnf-related apoptosis-inducing ligand's variant and the application thereof |
| 06/13/2013 | US20130150296 Albumin fusion proteins |
| 06/13/2013 | US20130150287 RECOMBINANT PROTEIN FOR INTRACELLULAR DELIVERY OF siRNA AND COMPOSITION COMPRISING THE SAME |
| 06/13/2013 | US20130150263 Human t2r nucleic acid sequences |
| 06/13/2013 | US20130149744 Methods for Producing a Fusion Protein Capable of Binding VEGF |
| 06/13/2013 | CA2857976A1 Novel antibiotic preparation method and platform system based on same |
| 06/13/2013 | CA2853138A1 Therapeutic use of anti-cd22 antibodies for inducing trogocytosis |
| 06/12/2013 | EP2601216A1 Covalent diabodies and uses thereof |
| 06/12/2013 | CN103153335A Small-molecule-targeted protein degradation |
| 06/12/2013 | CN103146734A Anti-burn and scald infection multiple organ failure Pseudomonas aeruginosa toxin vaccine |
| 06/12/2013 | CN103146733A Antibacterial recombination polypeptide and expression vector thereof |
| 06/12/2013 | CN103145855A Matrix metallo-proteinase inhibitor polypeptide and application thereof |
| 06/12/2013 | CN103145854A Recombined Tbeta 4-BP5 fusion peptide, gene, engineering bacteria and application |
| 06/12/2013 | CN103145853A Recombined Talpha 1-BP5 fusion peptide, gene, engineering bacteria and application |
| 06/12/2013 | CN103145852A Recombining human pleiotrophin fusion protein and method for preparing same |
| 06/12/2013 | CN103145851A Recombinant protein PACAP38-NtA, and coding gene and application thereof |
| 06/12/2013 | CN103145850A Substrate protein SNVP, and coding gene and application thereof |
| 06/12/2013 | CN103145849A Chimeric antigen receptor and its use |
| 06/12/2013 | CN103145848A Recombinant lactoferrin dipeptide, expression vector and application thereof |
| 06/12/2013 | CN103145847A Anti-CD20 antibody-monomethyl auristatin E conjugate, its preparation method and application |
| 06/12/2013 | CN103145846A Novel preparation method for TAT-Oct4 |
| 06/12/2013 | CN103145845A Expression of Tat and human wild-type P53 fusion protein in Pichia pastoris |
| 06/12/2013 | CN103145805A Heterozygosis antimicrobial peptide Lfcin-P-CecropinB (LPCB) and preparation method thereof |
| 06/12/2013 | CN101870735B High-glycosylation erythropoietin immune fusion protein |
| 06/12/2013 | CN101588817B Fully human high yield production system for improved antibodies and proteins |
| 06/12/2013 | CN101193911B Cysteine-depleted hydrophobin fusion proteins, their production and use thereof |
| 06/11/2013 | CA2567795C Methods of treating type i diabetes by blocking vegf-mediated activity |
| 06/11/2013 | CA2498004C Compositions and methods for the diagnosis and treatment of tumor |
| 06/11/2013 | CA2482607C Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 06/11/2013 | CA2468733C Antibodies against monocyte chemotactic proteins |
| 06/11/2013 | CA2442839C Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 06/11/2013 | CA2426012C Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 06/11/2013 | CA2407959C Human wingless-like gene |
| 06/11/2013 | CA2407603C Porphyromonas gingivalis recombinant proteins and truncations |
| 06/11/2013 | CA2406839C G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 06/06/2013 | WO2013082563A1 Protein inhibitors to complement and vegf pathways and methods of use thereof |
| 06/06/2013 | WO2013081233A1 Cell killing fusion peptide exhibiting tumor cell-specific necrosis induction and tumor regression |
| 06/06/2013 | WO2013081037A1 IgA-BINDING PEPTIDE AND PURIFICATION OF IgA THEREBY |
| 06/06/2013 | US20130144042 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/06/2013 | US20130143949 G-CSF Transferrin Fusion Proteins |
| 06/06/2013 | US20130142732 Recombinant fluorescent nanoparticles |
| 06/06/2013 | CA2857666A1 Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides |
| 06/06/2013 | CA2857567A1 Targeted lysosomal enzyme compounds |
| 06/06/2013 | CA2857548A1 Targeted enzyme compounds and uses thereof |
| 06/06/2013 | CA2857307A1 Methods and systems for protein refolding |
| 06/06/2013 | CA2857168A1 Protein inhibitors to complement and vegf pathways and methods of use thereof |
| 06/06/2013 | CA2857019A1 Novel enhanced selectin antagonists |
| 06/06/2013 | CA2856967A1 Therapeutic agents comprising insulin amino acid sequences |
| 06/06/2013 | CA2856480A1 Anticancer fusion protein |
| 06/05/2013 | EP2599503A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 06/05/2013 | EP2598631A1 Recombinant bacterium and uses thereof |
| 06/05/2013 | CN103131676A Silkworm recombinant baculovirus showing recombinant human tumor necrosis factor receptor-Fc fusion protein gene, and preparing method and application thereof |
| 06/05/2013 | CN103130898A TAT-LBD-PEP fusion protein and application of TAT-LBD-PEP fusion protein in treatment of central nervous system lesion |
| 06/05/2013 | CN102349995B Broad-spectrum antiviral medicament as well as preparation method and application thereof |
| 06/05/2013 | CN102276725B Cryptosporidium CTL and Th mixed multi-epitope gene and fusion protein and application |
| 06/05/2013 | CN102199208B Universal medicine delivery system and preparation method thereof |
| 06/05/2013 | CN102174110B Rabies virus glycoprotein-derived peptide and application thereof |
| 06/05/2013 | CN101993496B Dual blood sugar and blood fat adjusting fusion protein and preparation method and application thereof |
| 06/05/2013 | CN101969975B Chimeric HIV fusion proteins as vaccines |
| 06/05/2013 | CN101914564B Fusion of multiple enterotoxin genes of escherichia coli and application thereof |
| 06/05/2013 | CN101899419B Insect baculovirus expression system and method for expressing E2 protein using same |
| 06/05/2013 | CN101863984B Prostatic cancer therapeutic vaccine modified on surface of GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor)/TNF (Tumor Necrosis Factor)-alpha membrane |
| 06/05/2013 | CN101580871B Method for screening new drug for lowering cholesterol based on analysis of change of NPC1L1 protein subcellular localization |
| 06/05/2013 | CN101580548B Fusion peptide for inhibiting tumor growth and application thereof in preparing anti-tumor medicament |
| 06/05/2013 | CN101475642B AIDS virus recombinant antigen and fusion protein thereof |
| 06/05/2013 | CN101115771B 人类抗体和蛋白质 Human antibodies and proteins |
| 06/04/2013 | US8455449 Compositions and methods for modulating γ-c-cytokine activity |
| 06/04/2013 | US8455445 Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders |
| 06/04/2013 | US8454976 Recombinant toxin fragments |
| 05/30/2013 | WO2013078425A1 Lambodies with high affinity and selectivity for glycans and uses therefor |
| 05/30/2013 | WO2013075594A1 Artificially designed anti-hiv infection polypeptide, composition and use |
| 05/30/2013 | WO2013075553A1 Superantigen fusion protein targeting cancer and preparation method and use thereof |
| 05/30/2013 | WO2013025052A3 Bioactive carbon nanotube composite functionalized with β-sheet polypeptide block copolymer, and preparation method thereof |
| 05/30/2013 | WO2013022320A9 Amphipathic peptide-lipase conjugate having advanced lipase activity and use thereof |
| 05/30/2013 | US20130136760 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/30/2013 | US20130136741 Novel Enhanced Selectin Antagonists |
| 05/29/2013 | CN1911965B Binding domain-immunoglobulin fusion proteins |
| 05/29/2013 | CN103122033A Chimeric recombinant antigen and application thereof |
| 05/29/2013 | CN103122030A Hirulog as well as preparation method and application thereof |
| 05/29/2013 | CN102675473B Gene recombinant human active basic fibroblast growth factor fusion protein, preparation method thereof and application thereof |
| 05/29/2013 | CN102060930B HHscFv-Rcr functional protein and method for preparing transgenic tobacco |
| 05/28/2013 | US8450472 Isolated nucleic acid molecules encoding bitter taste receptor polypeptides and fragments thereof |
| 05/28/2013 | US8450457 T1R taste receptors and genes encoding same |
| 05/28/2013 | US8449889 Immuno-molecules containing viral proteins, compositions thereof and methods of using |
| 05/28/2013 | CA2710040C A soluble tumor necrosis factor receptor mutant |
| 05/28/2013 | CA2427902C Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/28/2013 | CA2412239C Cytokine receptor zcytor17 |
| 05/28/2013 | CA2324513C Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 05/28/2013 | CA2285692C Enhancement of immune response using targeting molecules |
| 05/28/2013 | CA2240292C Recombinant fusion proteins to growth hormone and serum albumin |